Literature DB >> 9631208

The 'Severe Impairment Battery': assessing cognitive ability in adults with Down syndrome.

P Witts1, S Elders.   

Abstract

OBJECTIVES: To examine the utility of the 'Severe Impairment Battery' (SIB--Thames Valley Test Company) in assessing cognitive ability of adults with Down syndrome.
DESIGN: A within-subject repeated measures design was used to determine test-retest reliability of the SIB and the Vineland Adaptive Behaviour Scales (Interview Edition--Survey Form, 1984) were used to establish SIB criterion validity.
METHODS: Thirty-three adults with Down syndrome (from 152 known to an NHS Trust learning disability service) were selected on the basis of their or their carers' written consent. At the first administration of the SIB with the participant, a staff member completed a Vineland ABS. Thirty days later, the SIB was readministered to the participant.
RESULTS: Test-retest reliability of the SIB was high as was criterion validity determined by correlating SIB and Vineland ABS scores. Floor effects were not encountered.
CONCLUSIONS: The SIB can successfully be used with adults with Down syndrome to assess cognitive functioning over a wide range of ability and may be useful, if used longitudinally, in assessing for deterioration in cognitive functioning associated with dementia. Methodological limitations are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9631208     DOI: 10.1111/j.2044-8260.1998.tb01295.x

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  8 in total

1.  Cognitive performance in centenarians and the oldest old: norms from the Georgia Centenarian Study.

Authors:  L Stephen Miller; Meghan B Mitchell; John L Woodard; Adam Davey; Peter Martin; Leonard W Poon; S M Jazwinski; R C Green; M Gearing; W R Markesbery; M A Johnson; J S Tenover; W L Rodgers; D B Hausman; J Arnold; I C Siegler
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2010-06-02

2.  Identifying dementia in Down syndrome with the Severe Impairment Battery, Brief Praxis Test and Dementia Scale for People with Learning Disabilities.

Authors:  E R Wallace; J P Harp; K L Van Pelt; L M Koehl; A M Caban-Holt; A J Anderson-Mooney; G A Jicha; D D Lightner; W C Robertson; E Head; F A Schmitt
Journal:  J Intellect Disabil Res       Date:  2021-11-16

3.  Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS).

Authors:  Carla M Startin; Erin Rodger; Lucy Fodor-Wynne; Sarah Hamburg; André Strydom
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

4.  Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review.

Authors:  Sarah Hamburg; Bryony Lowe; Carla Marie Startin; Concepcion Padilla; Antonia Coppus; Wayne Silverman; Juan Fortea; Shahid Zaman; Elizabeth Head; Benjamin L Handen; Ira Lott; Weihong Song; André Strydom
Journal:  J Neurodev Disord       Date:  2019-08-30       Impact factor: 4.025

5.  Longitudinal assessment of dementia measures in Down syndrome.

Authors:  Lisa Koehl; Jordan Harp; Kathryn L Van Pelt; Elizabeth Head; Frederick A Schmitt
Journal:  Alzheimers Dement (Amst)       Date:  2020-11-14

6.  (1)H-MRS metabolites in adults with Down syndrome: Effects of dementia.

Authors:  A-L Lin; D Powell; A Caban-Holt; G Jicha; W Robertson; B T Gold; R Davis; E Abner; D M Wilcock; F A Schmitt; E Head
Journal:  Neuroimage Clin       Date:  2016-06-02       Impact factor: 4.881

Review 7.  A critical literature review of the effectiveness of various instruments in the diagnosis of dementia in adults with intellectual disabilities.

Authors:  Jordan Elliott-King; Sarah Shaw; Stephan Bandelow; Rajal Devshi; Shelina Kassam; Eef Hogervorst
Journal:  Alzheimers Dement (Amst)       Date:  2016-06-30

8.  Neurocognitive assessments and long-term outcome in an adult with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency.

Authors:  Karolina M Stepien; Philomena McCarthy; Eileen P Treacy; James J O'Byrne; Gregory M Pastores
Journal:  Mol Genet Metab Rep       Date:  2018-06-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.